ARCHIVES

NCI Prepares For Intramural Program Review

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

CGAP Speeding Gene Discovery

April 30, 1999